Levodonna (Levonorgestrel)

Levonorgestrel works by binding to progesterone receptors, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus to impede sperm passage and modifies the uterine lining, making it less suitable for implantation.

The specific dose and regimen of Levodonna are determined by the prescribing healthcare professional based on the indication, patient weight, and timing relative to intercourse. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Levodonna is intended to prevent pregnancy and is not used during an established pregnancy. If pregnancy occurs after use, the product should be discontinued. Limited data exist for breastfeeding; clinicians usually advise caution and may recommend alternative contraception.

To request Levodonna, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levodonna (levonorgestrel) is a single‑dose progestin‑only option that is effective up to 72 hours after unprotected sex. Compared with ulipristal acetate, another emergency contraceptive, levonorgestrel is generally less effective after 72 hours but is widely available and does not require a prescription in many regions.

Levodonna should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf‑life.

Levodonna is taken orally, usually as a single tablet for emergency use or as a daily tablet for regular contraception, depending on the prescribing regimen. The tablet should be swallowed whole with water and not chewed or crushed.

Serious risks, although rare, include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions (anaphylaxis), and liver dysfunction. Patients should seek immediate medical attention if they experience unexplained leg swelling, shortness of breath, rash, or jaundice.

Levodonna is contraindicated in individuals with a known hypersensitivity to levonorgestrel or any tablet excipients, those with a history of thromboembolic disorders, hormone‑sensitive cancers, severe liver disease, or uncontrolled hypertension. Pregnant women should also avoid its use.